Author Details
Hakoshima, Mariko, Department of Internal Medicine, National Center for Global Health and Medicine Kohnodai Hospital, Chiba, Japan
-
Vol. 9, No. 5, May 2017 - Letter to the Editor
What Properties of Sodium-Glucose Cotransporter 2 Inhibitors Determine the Improvement in Hemoglobin A1c and Body Weight?
Abstract
HTML
PDF
-
Vol. 9, No. 7, Jul 2017 - Original Article
Effects of Six Kinds of Sodium-Glucose Cotransporter 2 Inhibitors on Metabolic Parameters, and Summarized Effect and Its Correlations With Baseline Data
Abstract
HTML
PDF
-
Vol. 10, No. 4, Apr 2018 - Review
An Improvement of Cardiovascular Risk Factors by Omega-3 Polyunsaturated Fatty Acids
Abstract
HTML
PDF
-
Vol. 10, No. 5, May 2018 - Review
Exercise Therapy for Patients With Type 2 Diabetes: A Narrative Review
Abstract
HTML
PDF
-
Vol. 10, No. 6, Jun 2018 - Original Article
Sodium-Glucose Cotransporter 2 Inhibitors Reduce Prandial Insulin Doses in Type 2 Diabetic Patients Treated With the Intensive Insulin Therapy
Abstract
HTML
PDF
-
Vol. 10, No. 7, Jul 2018 - Letter to the Editor
Which Factor Determines the Duration Required for Relief of Glucotoxicity by the Intensive Insulin Therapy?
Abstract
HTML
PDF
-
Vol. 11, No. 1, Jan 2019 - Letter to the Editor
An Effective Insulin Therapy in Combination With Sodium-Glucose Cotransporter 2 Inhibitors
Abstract
HTML
PDF
-
Vol. 11, No. 5, May 2019 - Letter to the Editor
Streptococcal Infection Can Be the Trigger for Thyroid Storm
Abstract
HTML
PDF
-
Vol. 11, No. 6, Jun 2019 - Original Article
Clinical, Biochemical, Hematological, Endocrinological and Immunological Differences Between Graves’ Disease Patients With and Without Thyroid Storm
Abstract
HTML
PDF
-
Vol. 11, No. 8, Aug 2019 - Letter to the Editor
Renoprotective Effect of Xanthine Oxidase Inhibitor, Topiroxostat
Abstract
HTML
PDF